Boston Scientific Predicts 2009 Will Be The Year Guidant Buy Proves Wise
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific CEO Jim Tobin says 2009 will be the year when his company's gamble on cardiac rhythm management begins to pay off the way it hoped when it entered the CRM business by buying Guidant in 2006